Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.
about
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisSynthetic high-density lipoprotein-like nanoparticles as cancer therapyHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesHigh-density lipoproteins for the systemic delivery of short interfering RNA.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementRegulation of platelet function by class B scavenger receptors in hyperlipidemiaReconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitusHigh density lipoprotein: it's not just about lipid transport anymoreApolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.HDL cholesterol efflux capacity and incident cardiovascular events.Aspirin for primary prevention of cardiovascular disease in diabetes mellitusPlatelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveNovel HDL-directed pharmacotherapeutic strategies.The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004.Cholesterol efflux assay.Novel biological functions of high-density lipoprotein cholesterolPlatelet function in the postprandial periodTargeting high density lipoproteins in the prevention of cardiovascular disease?High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphateDisordered haematopoiesis and athero-thrombosis.Cholesterol in platelet biogenesis and activation.HDL and endothelial protection.Regulation of signal transduction by HDL.Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondHDL endocytosis and resecretionDifferent relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.Aspirin resistance in patients with type II diabetes mellitus.Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Recombinant high-density lipoprotein formulations.The emerging role of HDL in glucose metabolism.Platelet function profiles in patients with diabetes mellitus.High-density lipoprotein as a modulator of platelet and coagulation responses.HDL-mediated mechanisms of protection in cardiovascular disease.High-density lipoprotein-based drug discovery for treatment of atherosclerosis.High-density lipoprotein mimetics: promises and challenges.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes.
P2860
Q26782972-F2F75E46-47B2-4E15-83D1-3993B7C748E9Q26825009-A8218E01-3146-4CA4-8DCA-5BCD73018A32Q28077290-98838B04-BCF8-4B16-8D52-BD17C2F61644Q33786171-69D8BBE5-57D2-4BB7-9B64-1EFC7BFDD87AQ34181381-808D9AFB-E22B-4205-A866-28825302AA85Q34397435-A91252C3-4B5F-4DAF-BFCB-78C76A2C29C6Q34560800-ACBB7D1D-A267-43A3-8E87-776D61B432F0Q34565254-AC8158D0-8EA0-43C5-8BF0-38486999B027Q34594140-B50F2E8E-C4B5-46B9-8551-275FC1CE8E85Q34765520-DA458055-BA4E-4F67-AC84-7CA5707D66F3Q34781496-3C44ACD0-52ED-4930-8C80-613052B669C7Q35021594-C8AD1654-D886-484A-95E9-594E7ACF6955Q35132896-CD2FCBF8-ABFD-411E-A0A6-E424BAEDE249Q35174193-EB095F02-0ED5-4F7A-81FD-B08F3D5880C0Q35860020-FBCE0C13-3B47-4BEF-8237-171D8CCAEEE5Q35898176-62CF31DE-2879-41BC-A8B1-0C1EAD96A99EQ36286514-A80B4D78-D518-40B0-A9D5-89A729F979DFQ36406480-1BBEE5FF-898D-47B6-BB96-CA2CE98DD324Q36411981-1C088882-4CF4-42FE-BA98-100AA67ECCEBQ36453173-5B3A4CFF-86F3-4EB1-9BE7-71B85C77A8D8Q36691031-C164C97D-F45F-4782-BCA4-CC7AF0D8E4B0Q36773876-260C6320-F73D-48F1-86C5-9CA170C31546Q36825794-DE506A07-B8FC-492D-AF0A-8CF967D7E7D4Q36929420-69AF6638-52FE-4886-B0FC-B7CA4A71D8AFQ37076473-85596AD8-6A65-4F9E-A700-505593DCCF70Q37162996-CAF3FD62-A2B9-423A-8AAC-43437A26F22CQ37226719-7ABF9E00-D2EB-4BF1-BBE2-00A695F7FFEBQ37251396-87FD0080-53E0-4579-A1E6-4D5A3605C32FQ37564161-47222592-B049-445F-AAC3-174F4A8AE526Q37774393-330C9C2F-E98D-4709-96C9-CB66080D3AAAQ37807911-1CAD5C32-B08A-4538-9A7B-D98E72F1A29DQ37978209-5C5A768D-B342-4BB5-BFDC-B26E4241C47CQ38081078-A021CF6E-EA67-4EED-B7E3-577A41F5D4BFQ38217201-4E3E31FC-B8AB-4F00-A8FC-B26D18001D11Q38220762-B198B8D1-A0DA-476F-B4DC-8DFCFCA6C134Q38506490-075E479C-62AF-46BC-BED5-16D3FF188249Q38650575-8B010B8B-38D6-481A-9889-46416B46DD54Q38822339-470B4CBC-7E75-4C5E-B4C0-6A8A35741AD8Q40645397-CECAFAEE-CF76-4814-86F1-B4DF380AEA6CQ42368055-6CD67AD1-DF68-4D59-9A46-778717674439
P2860
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Reconstituted high-density lip ...... promoting cholesterol efflux.
@en
type
label
Reconstituted high-density lip ...... promoting cholesterol efflux.
@en
prefLabel
Reconstituted high-density lip ...... promoting cholesterol efflux.
@en
P2093
P1433
P1476
Reconstituted high-density lip ...... promoting cholesterol efflux.
@en
P2093
Anna C Calkin
Brian G Drew
Bronwyn A Kingwell
Dmitri Sviridov
Mark E Cooper
Michelle V Gordon
Shaun P Jackson
Simone M Schoenwaelder
Stephen J Duffy
P304
P356
10.1161/CIRCULATIONAHA.109.870709
P407
P577
2009-11-09T00:00:00Z